Bevacizumab-containing chemotherapy is safe in patients with unresectable metastatic colorectal cancer and a synchronous asymptomatic primary tumor.

Cetin B, Kaplan MA, Berk V, Tufan G, Benekli M, Isikdogan A, Ozkan M, Coskun U, Buyukberber S.

Bevacizumab-containing chemotherapy is safe in patients with unresectable metastatic colorectal cancer and a synchronous asymptomatic primary tumor. Jpn J Clin Oncol.

2013 Jan;43(1):28-32. doi: 10.1093/jjco/hys175. Epub 2012 Oct 28. PubMed PMID: 23107836.